Objectives: The study aimed to gather information about the target population's knowledge, attitudes, and behaviors regarding HCV screening to develop effective communication strategies and improve service offerings.
Study Design: This was a Cross-Sectional study.
Methods: A target population random sample was submitted a phone questionnaire based on the Health Belief Model (HBF), containing 4 sections on perceived HCV susceptibility and severity, screening benefits and barriers. Each person interviewed was finally invited to adhere to the screening. Prevalence was estimated using a 95 % C.I., and association between sociodemographic characteristics, HBF attitudes, and screening adherence following the interview was assessed.
Results: Survey involved 641 participants. HCV susceptibility was perceived by 4.8 % (95 % CI 3.23-6.57) and HCV severity by 69.4 % (95 % CI 65.83-72.97), 95 % (95 % CI 93.3-96.6) acknowledged screening benefits and 88 % (95 % CI 85.4-90.5) perceived no barriers. Insufficient or no information about HCV or the screening was received by the 49.0 % (95 % CI 45.1-52.8) of people interviewed. Among these people, in the 2 months aftermath, 17.6 % carried out the HCV screening. Perception of screening barriers was associated with low education level (OR 1.83, P = 0.02).
Conclusions: Low adherence to the HCV screening could be explained with a poor perception of HCV susceptibility and gravity by the target population particularly with socioeconomic hurdles. Forthcoming communication campaign would need to focus on those factors to improve adherence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.puhe.2025.01.009 | DOI Listing |
Sci Rep
March 2025
AUSL - U.O.S.D. Oncology Screenings, Epidemiology and Health Promotion Programs, Local Health Agency of Ferrara, Corso Giovecca 203, 44121, Ferrara, Italy.
Hepatitis C virus (HCV) is a worldwide health hazard, and in chronic form (nowadays affecting 50 million people - World Health Organization data) can be lethal. To forestall it, preventive screening is a mandatory approach. Since 2021, Italy conducts a national-wide screening program to eliminate the virus from its population.
View Article and Find Full Text PDFClin Lymphoma Myeloma Leuk
February 2025
Clinic of Hematology, EOC, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Institute of Oncology Research, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland. Electronic address:
Current classifications identify 3 primary types of marginal zone lymphoma (MZL): extra nodal, splenic, and nodal MZL. MZLs typically have excellent long-term outcomes and often do not require immediate treatment. For asymptomatic patients, active surveillance (watch-and-wait) is the standard approach.
View Article and Find Full Text PDFPeople with mental health disorders have a significant lack of physical health care. They also have higher rates of medical co-morbidity. The aim of this study was to assess the feasibility and the linkage to care of systematic screening for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in patients admitted for an acute psychiatric event at the emergency department (ED).
View Article and Find Full Text PDFJ Racial Ethn Health Disparities
March 2025
Division of Epidemiology & Population Health Sciences, Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL, USA.
Aim: Examine racial and ethnic inequities in hepatitis C and B virus (HCV and HBV) screening across high-risk populations.
Subject And Methods: Chronic HCV and HBV infections can lead to cirrhosis, hepatocellular carcinoma (HCC), and death. Despite universal screening recommendations, < 50% of US adults are tested for these viruses.
Zhonghua Gan Zang Bing Za Zhi
February 2025
Infectious Disease Prevention and Treatment Center, the Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, China.
The Fuxing Program was established in Zhuhai as an action plan to micro-eliminate hepatitis C in response to the World Health Organization's goal of eliminating hepatitis C by 2030. Therefore, the effectiveness of this program in terms of hepatitis C screening, treatment, follow-up, and other aspects is evaluated here. The "Fuxing Project" was established in May 2021 under the supervision of the Zhuhai Medical Quality Control Center for Infectious Diseases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!